Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.7). Figures as of 18 Nov 2026, 15:42 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.4
Combined market value
SGD 1.08T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7SGD 47.3BSGD 320.16 1.00% down 49% up United States
2QiagenQGEN · Health Care4.9SGD 13.2BSGD 63.89 0.41% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.7SGD 21.1BSGD 208.36 2.62% down 20% up United States
4BioNTechBNTX · Health Care6.5SGD 26.8BSGD 108.17 1.15% down 16% down Germany
5AmgenAMGN · Health Care6.6SGD 311.3BSGD 575.43 2.55% down 34% up United States
6Gilead SciencesGILD · Health Care7.1SGD 269.1BSGD 216.98 1.17% down 33% up United States
7ExelixisEXEL · Health Care7.2SGD 21.5BSGD 88.27 0.07% down 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9SGD 14.2BSGD 124.30 0.44% up 37% up United States
9Bio-TechneTECH · Health Care9.4SGD 14.7BSGD 93.76 0.11% up 26% up United States
10argenxARGX · Health Care14.4SGD 77BSGD 1,224.85 0.24% up 4% up Belgium
11RepligenRGEN · Health Care14.7SGD 14BSGD 218.97 4.70% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.6SGD 5.9BSGD 36.67 0.18% down 88% up United States
13Twist BioscienceTWST · Health Care20.5SGD 10BSGD 146.17 1.21% up 340% up United States
14Krystal BiotechKRYS · Health Care23.1SGD 11.6BSGD 391.87 1.79% up 46% up United States
15ModernaMRNA · Health Care41.9SGD 105BSGD 259.46 2.71% down 755% up United States
16ImmunityBioIBRX · Health Care62.4SGD 9.1BSGD 8.57 6.16% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care263SGD 13.3BSGD 156.07 0.41% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1134SGD 5.1BSGD 52.91 2.19% up 21% down Switzerland
19CG OncologyCGON · Health Care1761SGD 9.2BSGD 102.72 0.91% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2895 SGD). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.7) have the lowest P/S ratio of the 19 biotech ranked here as of 18 Nov 2026, 15:42 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of SGD 1.08T as of 18 Nov 2026, 15:42 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.